Navigation Links
Viro-therapy against cancer

A new study conducted by the Researchers at the Hebrew University led to the isolation of a variant of the Newcastle Disease Virus (NDV-HUJ). This virus affects the birds but the variant has a high affinity toward cancer cells. //

Professors Amos Panet and Zichria Zakay-Rones, from the Department of Virology at the Hebrew University Hadassah Medical School, have conducted experiments with this variant virus for the past 5 years. They have said that it is possible to create a new and effective weapon to fight against cancer. If this experiment is a success then it will completely change the way we look at viruses.

Viruses are obligatory parasites that require a living cell in order to multiply. They insert their genetic material inside the host genome and thereby facilitate the production of viral components resulting in the death of the cell. In case of the NDV-HUJ virus it requires cancer cells as the host cell. NDV-HUJ is a natural variant of NDV (Newcastle Disease Virus) and an attenuated variant too. It does not affect the normal cells.

One of the possible explanations for this interesting behavior is that cancer cells have some deficiency in the interferon system. Interferons are anti-viral substances hence these variant viruses prefer attacking the cancerous cells.

Chemotherapy is effective against the cancerous cells but affects the healthy tissues, such as the hair, skin, digestive and immune systems. On the other hand the NDV-HUJ virus enables doctors to specifically target cancer cells without causing harm to the healthy tissue.

Viro-therapy is a very old therapy originating in the 20th Century. The first stage o the research unraveled the NDV-HUJ genome, which has 6 genes and 15,068 nucleotides. Then it compared it with other strain of the NDV virus.

Then it studied the apoptotic mechanism of the virus. The NDV-HUJ virus treatment was experimented on 14 patients suffering from Glioblastoma Multiforme, (GBM), an aggressive type of primary brain tumor surprisingly they showed regression of the tumor. So far no side effects were observed. Further research has to be done regarding the Viro-therapy. But this would be the stepping-stone into the new era of cancer therapy.


'"/>




Related medicine news :

1. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
2. Man against HIV – new vaccine ready for human trials
3. Antibiotics losing their power against acne
4. South Africa Wins landmark case against pharmaceutical giants
5. Vitamin E, the latest warrior against diabetes
6. Acne may protect against infections
7. Fight against E.coli
8. Defence against free radicals
9. Progestin protects against ovarian cancer
10. Beverage protect against bladder cancer
11. Moderate alcohol consumption protects against dementia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: